Ultrahuman raises $70M to scale health wearables R&D and AI

Bengaluru-based Ultrahuman has raised $70 million from Qualcomm Ventures, Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners and Alteria. The wearable-health company plans to invest in sensing, AI, miniaturised electronics, clinical science and health algorithms.

— Source publishedFri, 4 Sept, 2026, 10:04 IST·First seen Fri, 4 Sept, 2026, 10:10 IST·Source YourStory · Capital

What happened

Bengaluru-based wearable health company Ultrahuman raised $70 million from Qualcomm Ventures, Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners and

Key facts

  • $70 million
  • next decade

Why this matters

Strategic buyers should view Ultrahuman’s funding as evidence that differentiated wearable-health capabilities—especially sensors, health algorithms and clinical data assets—are becoming increasingly valuable acquisition or partnership targets.

What to watch

  • New sensor, ring, watch or patch product announcements and stated launch timing.
  • Evidence of FDA-cleared, clinically validated or lab-integrated health features.
  • Subscription attach rate, membership pricing changes and recurring-revenue disclosures.
  • Retail distribution agreements with major electronics, fitness, pharmacy or department-store chains.
  • Competitive product releases or pricing moves from Oura, Samsung, Apple and Garmin.
  • Signs of manufacturing scale-up, delivery lead-time improvement or international market entry.
  • Launch upgraded ring or adjacent wearable with expanded metabolic, sleep, recovery or cardiovascular sensing.
  • Increase AI coaching and subscription features to raise customer lifetime value.
  • Pursue clinical-validation studies and partnerships with labs, insurers, employers and healthcare providers.
  • Expand offline retail, marketplace distribution and international availability.
  • Use Qualcomm relationship to improve chipset, connectivity and on-device AI capabilities.

Also reported by